Tongqiao Biyan Tablets
Natural health product licensed in Canada
- Other names
- Astraglus and Xanthium Formula, Rhinitis and Nasal Congestion Relief
- Licence holder
- 11741217 Canada Inc.
- NPN or DIN-HM
- 80132192
- Status
- Active licence
- Licence date
- 4 July 2024
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Mentha canadensis Source : Mentha canadensis - Sommité (herbe) Extract : Matériel brut sec Extraction ratio : 6.061:1 Dry plant equivalent : 50 mg | 8.25 mg | Not calculated |
| Astragalus membranaceus Source : Astragalus membranaceus - racine Extract : Matériel brut sec Extraction ratio : 6.064:1 Dry plant equivalent : 250 mg | 41.23 mg | Not calculated |
| Atractylodes macrocephala | 80 mg | Not calculated |
Non-medicinal ingredients
Glycolate d'amidon sodique, Sucrose, Amidon de maïs, Hydroxypropyl méthylcellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | minimum: 5 Comprimé ; maximum: 7 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine. Used in Traditional Chinese Medicine (TCM) to disperse wind, secure the exterior, diffuse the lung, and open the orifices. Used in Traditional Chinese Medicine for pattern of retained wind-heat in the lung and insecurity of the exterior,manifested as recurrent nasal congestion with clear or thick nasal discharge,and frontal headache;Chronic rhinitis,allergic rhinitis and nasal sinusitis with the symptoms described above.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80132192
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.